Systematic review with meta-analysis: comparative efficacy of biologics for induction and maintenance of mucosal healing in Crohn's disease and ulcerative colitis controlled trials.
about
New treatment strategies for ulcerative colitis.Access to biologicals in Crohn's disease in ten European countriesSystematic review and network meta-analysis: first- and second-line pharmacotherapy for moderate-severe ulcerative colitis.Association of miR-146 rs2910164, miR-196a rs11614913, miR-221 rs113054794 and miR-224 rs188519172 polymorphisms with anti-TNF treatment response in a Greek population with Crohn's disease.Comparative Effectiveness of Infliximab Versus Adalimumab in Patients with Biologic-Naïve Crohn's Disease.A Survey Study of Gastroenterologists' Attitudes and Barriers Toward Therapeutic Drug Monitoring of Anti-TNF Therapy in Inflammatory Bowel Disease.Letter: biologics treatment in Crohn's disease and risk of bowel resection-what about the patients who stop anti-TNF therapy?Editorial: tofacitinib and biologics for moderate-to-severe ulcerative colitis-what is best in class?Editorial: biologics in inflammatory bowel disease-time for direct comparisons.Vedolizumab Treatment for Ulcerative Colitis in an Elderly Multimorbid Patient with Hemophilia A.Subtherapeutic concentrations of infliximab and adalimumab are associated with increased disease activity in Crohn's disease.A Noninvasive Method to Assess Mucosal Healing in Patients* With Crohn’s Disease.Effectiveness and safety of adalimumab to treat outpatient ulcerative colitis: A real-life multicenter, observational study in primary inflammatory bowel disease centersIndoleamine 2,3-dioxygenase-dependent expansion of T-regulatory cells maintains mucosal healing in ulcerative colitis
P2860
Q38670811-52188E56-2767-4725-96C7-3DCBC401F0FAQ42044847-78680018-45C4-407C-A497-C567C09B954BQ46345854-252B4823-FCAE-48D0-99F9-87385322E068Q47142918-CC61924E-448C-407C-B4A8-585FE8CC4BBBQ47192581-9BDD7B79-1A1A-494A-9991-90B5C1E6206BQ47258474-056DB269-82DA-4E4E-8969-C19401CAFE0AQ47309441-8588D970-545D-471E-81DC-8ACBFA8DFC0FQ48228653-50ECD1DD-13F6-4F4C-8545-7F3A5C129763Q48315875-DDD78B28-3CB4-4746-BEAE-E884EBA91B2CQ52614638-EE210629-D0EB-4A50-8DF8-A7635A5D35AAQ55432449-7A5146DB-0F44-4809-AB45-03861AFB892CQ55512054-6628CB77-FC30-485E-9B64-D177F97D8858Q58706830-FF6DA963-44C6-42AE-B156-BD215093361FQ58707093-11589B87-C141-4948-B0ED-831648582088
P2860
Systematic review with meta-analysis: comparative efficacy of biologics for induction and maintenance of mucosal healing in Crohn's disease and ulcerative colitis controlled trials.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Systematic review with meta-an ...... ive colitis controlled trials.
@en
type
label
Systematic review with meta-an ...... ive colitis controlled trials.
@en
prefLabel
Systematic review with meta-an ...... ive colitis controlled trials.
@en
P2093
P2860
P356
P1476
Systematic review with meta-an ...... ive colitis controlled trials.
@en
P2093
A Cholapranee
G G Kaplan
L Peyrin-Biroulet
P2860
P304
P356
10.1111/APT.14030
P407
P577
2017-03-22T00:00:00Z